G Johan A Offerhaus
Overview
Explore the profile of G Johan A Offerhaus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
166
Citations
7318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hackeng W, Dreijerink K, de Leng W, Morsink F, Valk G, Vriens M, et al.
Clin Cancer Res
. 2020 Dec;
27(5):1341-1350.
PMID: 33355250
Purpose: The primary origin of neuroendocrine tumor metastases can be difficult to determine by histopathology alone, but is critical for therapeutic decision making. DNA methylation-based profiling is now routinely used...
12.
Dang H, van Pelt G, Haasnoot K, Backes Y, Elias S, Seerden T, et al.
United European Gastroenterol J
. 2020 Nov;
:2050640620975324.
PMID: 33210982
Background: Current risk stratification models for early invasive (T1) colorectal cancer are not able to discriminate accurately between prognostic favourable and unfavourable tumours, resulting in over-treatment of a large (>80%)...
13.
Berbecka M, Kolasinska-Bzoma M, Kolasinska-Gliwa E, Polkowski W, Offerhaus G, Maciejewski R, et al.
Ann Agric Environ Med
. 2020 Sep;
27(3):469-475.
PMID: 32955231
Introduction: Currently, malignancies are the most severe medical problems worldwide. Numerous, already known risk factors in carcinogenesis could be potentially avoided. Some cancer risk factors have been recognized and have...
14.
Szlendak M, Sitarz R, Berbecka M, Mielko J, Morsink F, Maciejewski R, et al.
Mol Clin Oncol
. 2020 Sep;
13(5):52.
PMID: 32874582
In colorectal cancer (CRC), pathological factors that correlate with negative prognosis include, among others, overexpression of cyclooxygenase-2 (COX-2) and abundant expression of mucin 1 (MUC1). COX-2 overexpression may therefore be...
15.
Noe M, Niknafs N, Fischer C, Hackeng W, Beleva Guthrie V, Hosoda W, et al.
Nat Commun
. 2020 Aug;
11(1):4085.
PMID: 32796935
Intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs) are non-invasive neoplasms that are often observed in association with invasive pancreatic cancers, but their origins and evolutionary relationships are...
16.
Kranendonk M, Hackeng W, Offerhaus G, Morsink F, Jonges G, Groenewegen G, et al.
Diagn Pathol
. 2020 Jul;
15(1):99.
PMID: 32711552
Background: Molecular diagnostics can be decisive in the differential diagnosis between a somatic metastasis of type II testicular germ cell tumor (TGCT) or a second primary carcinoma. This is in...
17.
Machlowska J, Kapusta P, Baj J, Morsink F, Wolkow P, Maciejewski R, et al.
Cancers (Basel)
. 2020 Jul;
12(7).
PMID: 32708070
Background: Gastric cancer is the fourth most common cause of cancer-related death. Currently, it is broadly accepted that the molecular complexity and heterogeneity of gastric cancer, both inter- and intra-tumor,...
18.
Haasnoot K, Backes Y, Moons L, Kranenburg O, Trinh A, Vermeulen L, et al.
Mod Pathol
. 2020 Jun;
33(12):2626-2636.
PMID: 32581367
Advanced colorectal cancer (CRC) consensus molecular subtype 4 (CMS4) or CRC with a low immunoscore is associated with shorter survival times. Non-metastatic CRC with microsatellite instability (MSI) is associated with...
19.
Hoevenaar W, Janssen A, Quirindongo A, Ma H, Klaasen S, Teixeira A, et al.
Nat Commun
. 2020 Mar;
11(1):1501.
PMID: 32198375
Most human cancers are aneuploid, due to a chromosomal instability (CIN) phenotype. Despite being hallmarks of cancer, however, the roles of CIN and aneuploidy in tumor formation have not unequivocally...
20.
Hackeng W, Schelhaas W, Morsink F, Heidsma C, van Eeden S, Valk G, et al.
Endocr Pathol
. 2020 Feb;
31(2):108-118.
PMID: 32103422
Insulin-producing pancreatic neuroendocrine tumors (PanNETs)/insulinomas are generally considered to be indolent tumors with an excellent prognosis after complete resection. However, some insulinomas have a poor prognosis due to relapses and...